Alain Brecx

2PUBLICATIONS
9CO-AUTHORS
Epidemiological methodsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Apr 30, 2020
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials.

Romulo Colindres, Valentine Wascotte, Alain Brecx

|Jul 21, 2018
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.

Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres

Pageof 1

Frequent Collaborators

1 joint publications

Valentine Wascotte

1 joint publications

Christopher Clarke

1 joint publications

Caroline Hervé

1 joint publications

Joon Hyung Kim

1 joint publications

Myron J Levin

1 joint publications

Lidia Oostvogels

1 joint publications

Toufik Zahaf

1 joint publications

Anne Schuind

1 joint publications

Anthony L Cunningham

Frequent Collaborators

1 joint publications

Valentine Wascotte

1 joint publications

Christopher Clarke

1 joint publications

Caroline Hervé

1 joint publications

Joon Hyung Kim

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

9.1K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Published on : Mar 16, 2022

2.2K
See more related videos

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

9.1K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Published on : Mar 16, 2022

2.2K
See more related videos